Evidence map›Paper›PMID 37077550›Full record

ArticleERJ open research2023

ERS International Congress 2022: highlights from the Interstitial Lung Diseases Assembly.

Theodoros Karampitsakos, Phuong Phuong Diep, Daan W Loth, Iftikhar Nadeem, Elene Khurtsidze, Marlies S Wijsenbeek, Wim A Wuyts, Elena Bargagli, Antoine Froidure, Paolo Spagnolo and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Theodoros KarampitsakosDepartment of Respiratory Medicine, University Hospital of Patras, Rio, Greece.ORCID https://orcid.org/0000-0003-0804-6292
Phuong Phuong DiepDepartment of Respiratory Medicine, University Hospital of Oslo, Oslo, Norway.
Daan W LothDepartment of Respiratory Medicine, Amphia Hospital, Breda, The Netherlands.
Iftikhar NadeemDepartment of Respiratory Medicine, Royal Papworth Hospital NHS Trust, Cambridge, UK.ORCID https://orcid.org/0000-0002-8644-925X
Elene KhurtsidzeDepartment of Internal Medicine, New Vision University, Tbilisi, Georgia.ORCID https://orcid.org/0000-0001-9388-8931
Marlies S WijsenbeekDepartment of Respiratory Medicine, ILD Center of Excellence, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
Wim A WuytsUnit for Interstitial Lung Disease, Dept of Respiratory Medicine, University Hospitals Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0001-9648-3497
Elena BargagliRespiratory Diseases Unit, Department of Medical, Surgery and Neurosciences, Siena University, Siena, Italy.
Antoine FroidureService de Pneumologie, Cliniques Universitaires Saint-Luc and Institut de Recherche Expérimentale, UCLouvain, Brussels, Belgium.
Paolo SpagnoloRespiratory Disease Unit, Dept of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padua, Italy.
Marcel VeltkampILD Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Nieuwegein, The Netherlands.
Maria Molina-MolinaDept of Pneumology, Unit of Interstitial Lung Diseases, University Hospital of Bellvitge Institute for Biomedical Research (IDIBELL), Barcelona, Spain.
Cormac McCarthyUCD School of Medicine, Education and Research Centre, St Vincent's University Hospital, Dublin, Ireland.
Katerina M AntoniouLaboratory of Molecular and Cellular Pneumonology Laboratory, Dept of Respiratory Medicine, School of Medicine, University of Crete, Crete, Greece.
Michael KreuterCenter for Interstitial and Rare Lung Diseases, and Interdisciplinary Center for Sarcoidosis, Pneumology, Thoraxklinik, University Hospital Heidelberg and German Center for Lung Research, Heidelberg, Germany.ORCID https://orcid.org/0000-0003-4402-2159
Catharina C MoorDepartment of Respiratory Medicine, ILD Center of Excellence, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID https://orcid.org/0000-0002-5295-2877

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article contains a selection of scientific highlights in the field of interstitial lung diseases (ILDs) presented at the hybrid European Respiratory Society International Congress 2022. Early Career Members of Assembly 12 summarise recent advances in translational and clinical research in idiopathic interstitial pneumonias, ILDs of known origin, sarcoidosis and other granulomatous diseases, and rare ILDs. Many studies focused on evaluation of diagnostic and prognostic (bio)markers, and novel pharmacological and nonpharmacological treatment options for different ILDs. In addition, new insights in clinical, physiological and radiological features of various rare ILDs were presented.

Identifiers

PMID37077550
PMCPMC10107062

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.